Related references
Note: Only part of the references are listed.RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
Õsa Ehlén et al.
Translational Oncology (2014)
High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
Liv Jonsson et al.
BIOMARKER RESEARCH (2014)
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
Karolina Boman et al.
BMC UROLOGY (2013)
EAU Guidelines on Testicular Cancer: 2011 Update
P. Albers et al.
ACTAS UROLOGICAS ESPANOLAS (2012)
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
Liv Jonsson et al.
DIAGNOSTIC PATHOLOGY (2011)
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group
Sven-Erik Olofsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group
Torgrim Tandstad et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmo Diet and Cancer Study
Liv Jonsson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
Barbara Hjelm et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
Asa Ehlen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
The RNA-Binding Protein RBM3 Is Required for Cell Proliferation and Protects Against Serum Deprivation-Induced Cell Death
Sven Wellmann et al.
PEDIATRIC RESEARCH (2010)
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
Annika Jogi et al.
MODERN PATHOLOGY (2009)
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
Susanne Krege et al.
EUROPEAN UROLOGY (2008)
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I
Susanne Krege et al.
EUROPEAN UROLOGY (2008)
Randomized trial comparing Bleomycin/Etoposide/Cisplatin with alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors:: Genito-urinary group of the french federation of cancer Centers trial T93MP
Stephane Culine et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe
S. M. Sureban et al.
ONCOGENE (2008)
DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy
J. Bartkova et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2007)
Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis
MR van Dijk et al.
EUROPEAN JOURNAL OF CANCER (2006)
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
SD Fosså et al.
BRITISH JOURNAL OF CANCER (2005)
Decreased expression of mouse Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis
S Danno et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
